
Sign up to save your podcasts
Or


In this episode we navigate another difficult disease to treat, that is antibody-mediated rejection of kidney transplants, a disease that currently has no effective standard treatment. Luckily, new therapy is on the horizon, and the sunrise will be coming soon. Georg Böhmig has been involved in most of the exciting new research done in this field and will inform us of all the novelties that are just around the corner.
By European Renal Association3
22 ratings
In this episode we navigate another difficult disease to treat, that is antibody-mediated rejection of kidney transplants, a disease that currently has no effective standard treatment. Luckily, new therapy is on the horizon, and the sunrise will be coming soon. Georg Böhmig has been involved in most of the exciting new research done in this field and will inform us of all the novelties that are just around the corner.

7,617 Listeners

325 Listeners

498 Listeners

3,360 Listeners

1,143 Listeners

14 Listeners

369 Listeners

172 Listeners

84 Listeners

374 Listeners

8 Listeners

135 Listeners

327 Listeners